Tag: carcinoid syndrome clinical trial
![siemens biograph mmr system1](https://www.carcinoid.org/wp-content/uploads/2011/06/siemens-biograph-mmr-system1.jpg)
Up-to-the-Minute: News for the Carcinoid and Neuroendocrine Tumor Community
June 12, 2011
The first device that simultaneously performs PET and MRI scans, a new alpha-emitter-based therapy for NET cancer patients with progressive therapy-resistant tumors, the first–ever randomized virtual clinical trial, over 100 abstracts on carcinoid…
READ MORE![arthur t sands md phd president and chief executive officer lexicon pharmaceuticals5](https://www.carcinoid.org/wp-content/uploads/2010/09/arthur-t-sands-md-phd-president-and-chief-executive-officer-lexicon-pharmaceuticals5.jpg)
Lexicon Pharmaceuticals, Inc. Clinical Trial Recruiting Carcinoid Syndrome Patients
September 10, 2010
Patients with carcinoid syndrome, whose symptoms are not managed by octreotide therapy, are being recruited for a Phase 2 clinical trial of Lexicon Pharmaceuticals’ LX1606 (a.k.a. LX1032). The trial has been given Fast Track status in the U.S. and …
READ MORE